Clinical trial
Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and…
NCT00442741 · Novartis Pharmaceuticals, Industry · Withdrawn
Key facts
| NCT number | NCT00442741 |
|---|---|
| Title | Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) |
| Official title | An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Solid Tumors |
| Intervention type | Drug |
| Interventions | Patupilone, Patupilone + Omeprazole |
| Enrollment | 0 |
| Start date | Jul 1, 2007 |
| Primary completion | Jul 1, 2007 |
| First posted | Mar 2, 2007 |
| Last update posted | Apr 25, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: